BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Donovan P, Cato K, Legaie R, Jayalath R, Olsson G, Hall B, Olson S, Boros S, Reynolds BA, Harding A. Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors. Mol Biosyst. 2014;10:741-758. [PMID: 24448662 DOI: 10.1039/c3mb70484j] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Coward J, Harding A. Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer. Front Oncol 2014;4:123. [PMID: 24904834 DOI: 10.3389/fonc.2014.00123] [Cited by in Crossref: 102] [Cited by in F6Publishing: 99] [Article Influence: 12.8] [Reference Citation Analysis]
2 Kimmel GJ, Dane M, Heiser LM, Altrock PM, Andor N. Integrating Mathematical Modeling with High-Throughput Imaging Explains How Polyploid Populations Behave in Nutrient-Sparse Environments. Cancer Res 2020;80:5109-20. [PMID: 32938640 DOI: 10.1158/0008-5472.CAN-20-1231] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Piancastelli LSC, Barreto-souza W, Mayrink VD. Generalized inverse-Gaussian frailty models with application to TARGET neuroblastoma data. Ann Inst Stat Math 2021;73:979-1010. [DOI: 10.1007/s10463-020-00774-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Thura M, Ye Z, Al-Aidaroos AQ, Xiong Q, Ong JY, Gupta A, Li J, Guo K, Ang KH, Zeng Q. PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse. Commun Biol 2021;4:923. [PMID: 34326464 DOI: 10.1038/s42003-021-02449-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Jemaà M, Manic G, Lledo G, Lissa D, Reynes C, Morin N, Chibon F, Sistigu A, Castedo M, Vitale I, Kroemer G, Abrieu A. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition. Oncotarget 2016;7:885-901. [PMID: 26637805 DOI: 10.18632/oncotarget.6432] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
6 Saleh T, Carpenter VJ, Bloukh S, Gewirtz DA. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies. Semin Cancer Biol 2020:S1044-579X(20)30270-4. [PMID: 33358748 DOI: 10.1016/j.semcancer.2020.12.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Baudoin NC, Bloomfield M. Karyotype Aberrations in Action: The Evolution of Cancer Genomes and the Tumor Microenvironment. Genes (Basel) 2021;12:558. [PMID: 33921421 DOI: 10.3390/genes12040558] [Reference Citation Analysis]
8 Farina AR, Cappabianca LA, Zelli V, Sebastiano M, Mackay AR. Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting. World J Stem Cells 2021; 13(7): 685-736 [PMID: 34367474 DOI: 10.4252/wjsc.v13.i7.685] [Reference Citation Analysis]
9 Brito A, Merle C, Lagarde P, Faustin B, Devin A, Lartigue L, Chibon F. Cell fusion enhances energy metabolism of mesenchymal tumor hybrid cells to sustain their proliferation and invasion. BMC Cancer 2021;21:863. [PMID: 34320948 DOI: 10.1186/s12885-021-08561-6] [Reference Citation Analysis]
10 Thomson GJ, Hernon C, Austriaco N, Shapiro RS, Belenky P, Bennett RJ. Metabolism-induced oxidative stress and DNA damage selectively trigger genome instability in polyploid fungal cells. EMBO J 2019;38:e101597. [PMID: 31448850 DOI: 10.15252/embj.2019101597] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
11 Yant L, Bomblies K. Genome management and mismanagement--cell-level opportunities and challenges of whole-genome duplication. Genes Dev 2015;29:2405-19. [PMID: 26637526 DOI: 10.1101/gad.271072.115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
12 Candiota AP, Arús C. Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives. Metabolites 2022;12:243. [DOI: 10.3390/metabo12030243] [Reference Citation Analysis]